Viruses have long been suspected as
a cause of Chronic Fatigue Syndrome or CFS, but research studies have
been
mixed, in part because we lack the tools to detect the viruses we
suspect.
The sudden onset of CFS in some patients with an “infectious-like” illness,
the nature of some of the symptoms, and the state of chronic immune
activation suggest that chronic fatiguing illnesses can be triggered
and perpetuated by a virus. CFS symptoms have been described in
a variety of acute infections (Leventhal
et al., 1991; Rosene et
al.,
1982; Cluff et al., 1959; Salit,
1985.). Many investigators have
reported enteroviral infections in CFS (Cunningham
et al., 1990; Gow
et al., 1991, 1996;
Bowles
et al., 1993; Clements
et al., 1995; Richardson, 1995; Richardson,
1995; Soteriou et al., 1996). Also, a number of studies have suggested
that parvovirus can produce CFS (Kerr
et al., 2001, 2002; Matano
et al., 2003).
A recent observational study has confirmed the existence of a post-infectious
fatigue syndrome and provided clues as to its etiology. Hickie and
colleagues identified all cases of acute infection with Epstein-Barr
virus (a DNA virus),
|
Ross River virus (an RNA virus),
and Coxiella burnetii in one township in rural Australia ( Hickie
et al., 2006). The study involved 253 patients and found that post-infectious
fatigue syndrome was present in 12% of the patients six months after
their acute infection. Virtually all the patients met the CDC criteria
for CFS. Other studies have shown that antiviral pathways are activated
in CFS patients ( Suhadolnik
1997, Gow
2001). Gene expression profiling
has found an up-regulation of mitochondrial translation initiation
factor EIF4G1, which is consistent with persistent viral infection
( Kerr
2005).
CFS has been associated with reduced NK cell activity, reduced TH1 cell activity,
activated TH2 and increased Tc cell activity, all findings consistent with long-term
viral infections. (Komaroff, 2006)
Also, viral infections reduce blood fatty acid levels, which are reduced in patients
with CFS ( Puri
2006). Finally, antiviral treatments (Ampligen, Isoprinosine,
beta interferon, valganciclovir) have been somewhat effective in small studies
( Strayer,
1994, Newport Pharmaceuticals; See, 1996; Montoya 2006). |